Dr. Mohammad Al-Efashad joins the show to spotlight Pancreatic Cancer Awareness Month. Once considered a near-certain death sentence, pancreatic cancer now sees improved survival rates—especially with early detection. Dr. Mo breaks down why this aggressive disease often evades early diagnosis, the lack of widespread screening, and the importance of recognizing subtle symptoms. He shares insights on prevention, high-risk screening protocols, and the evolving treatment landscape, including robotic surgery and chemotherapy timing. With only 60,000 cases annually, pancreatic cancer still ranks second in cancer-related deaths—making awareness and innovation more critical than ever.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.